Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial.
Solberg A, Widmark A, Tasdemir I, Ahlgren G, Angelsen A. Solberg A, et al. Among authors: widmark a. Scand J Urol Nephrol. 2011 Sep;45(4):233-8. doi: 10.3109/00365599.2011.560577. Epub 2011 Mar 31. Scand J Urol Nephrol. 2011. PMID: 21452932 Clinical Trial.
Treatment of patients with clinical T3 prostate cancer.
Aus G, Adolfsson J, Selli C, Widmark A. Aus G, et al. Among authors: widmark a. Scand J Urol Nephrol. 2002 Feb;36(1):28-33. doi: 10.1080/003655902317259337. Scand J Urol Nephrol. 2002. PMID: 12002354 Review.
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andrén O, Bill-Axelson A, Bratt O, Damber JE, Hellström K, Hellström M, Holmberg E, Holmberg L, Hugosson J, Johansson JE, Petterson B, Törnblom M, Widmark A, Stattin P. Adolfsson J, et al. Among authors: widmark a. Scand J Urol Nephrol. 2007;41(6):456-77. doi: 10.1080/00365590701673625. Scand J Urol Nephrol. 2007. PMID: 17934985
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.
Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD; Scandinavian Prostate Cancer Group Study 7; Swedish Association for Urological Oncology 3. Widmark A, et al. Lancet. 2009 Jan 24;373(9660):301-8. doi: 10.1016/S0140-6736(08)61815-2. Epub 2008 Dec 16. Lancet. 2009. PMID: 19091394 Free article. Clinical Trial.
Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial.
Fransson P, Lund JA, Damber JE, Klepp O, Wiklund F, Fosså S, Widmark A; Scandinavian Prostate Cancer Group Study 7; Swedish Association for Urological Oncology 3. Fransson P, et al. Among authors: widmark a. Lancet Oncol. 2009 Apr;10(4):370-80. doi: 10.1016/S1470-2045(09)70027-0. Epub 2009 Mar 13. Lancet Oncol. 2009. PMID: 19286422 Clinical Trial.
171 results